Cleveland Research Downgrades Oracle (ORCL) to Neutral

Oracle (NYSE:ORCL) was downgraded by research analysts at Cleveland Research from a “buy” rating to a “neutral” rating in a report released on Tuesday.

A number of other analysts have also commented on ORCL. Vetr lowered Oracle from a “buy” rating to a “hold” rating and set a $51.30 price objective on the stock. in a research note on Thursday, February 15th. Credit Suisse Group reaffirmed a “buy” rating and set a $62.00 price objective on shares of Oracle in a research note on Sunday. Instinet assumed coverage on Oracle in a research note on Wednesday, January 24th. They set a “buy” rating and a $51.12 price objective on the stock. ValuEngine raised Oracle from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Finally, BMO Capital Markets decreased their price objective on Oracle from $57.00 to $55.00 and set an “outperform” rating on the stock in a research note on Friday, December 15th. One research analyst has rated the stock with a sell rating, twelve have issued a hold rating and twenty-nine have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $55.38.

Oracle (NYSE:ORCL) traded down $0.71 during trading on Tuesday, reaching $50.00. The company’s stock had a trading volume of 4,165,217 shares, compared to its average volume of 16,327,672. The company has a debt-to-equity ratio of 1.03, a current ratio of 5.07 and a quick ratio of 5.04. The firm has a market capitalization of $207,560.00, a price-to-earnings ratio of 21.45, a price-to-earnings-growth ratio of 1.93 and a beta of 1.08. Oracle has a 12 month low of $41.93 and a 12 month high of $53.14.

Oracle (NYSE:ORCL) last posted its earnings results on Thursday, December 14th. The enterprise software provider reported $0.70 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.68 by $0.02. The company had revenue of $9.63 billion for the quarter, compared to analyst estimates of $9.57 billion. Oracle had a return on equity of 20.49% and a net margin of 25.48%. Oracle’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.61 earnings per share. equities research analysts anticipate that Oracle will post 2.68 earnings per share for the current fiscal year.

Oracle declared that its board has approved a share repurchase program on Thursday, December 14th that permits the company to repurchase $12.00 billion in outstanding shares. This repurchase authorization permits the enterprise software provider to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s board of directors believes its stock is undervalued.

In other news, Director Hector Garcia-Molina sold 3,750 shares of the stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $49.66, for a total value of $186,225.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Thomas Kurian sold 1,700,000 shares of the stock in a transaction dated Thursday, January 18th. The shares were sold at an average price of $50.29, for a total value of $85,493,000.00. Following the completion of the sale, the insider now owns 1,522,983 shares of the company’s stock, valued at approximately $76,590,815.07. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 1,956,250 shares of company stock worth $98,316,475. Company insiders own 29.00% of the company’s stock.

Several hedge funds have recently bought and sold shares of ORCL. Acrospire Investment Management LLC grew its stake in Oracle by 947.4% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,990 shares of the enterprise software provider’s stock valued at $100,000 after purchasing an additional 1,800 shares in the last quarter. Burt Wealth Advisors grew its stake in Oracle by 4.3% during the 2nd quarter. Burt Wealth Advisors now owns 2,151 shares of the enterprise software provider’s stock valued at $107,000 after purchasing an additional 88 shares in the last quarter. Tarbox Family Office Inc. grew its stake in Oracle by 71.1% during the 4th quarter. Tarbox Family Office Inc. now owns 2,322 shares of the enterprise software provider’s stock valued at $110,000 after purchasing an additional 965 shares in the last quarter. Wealthcare Advisory Partners LLC grew its stake in Oracle by 81,200.0% during the 3rd quarter. Wealthcare Advisory Partners LLC now owns 2,439 shares of the enterprise software provider’s stock valued at $118,000 after purchasing an additional 2,436 shares in the last quarter. Finally, Cerebellum GP LLC acquired a new stake in Oracle during the 4th quarter valued at approximately $126,000. Institutional investors and hedge funds own 58.36% of the company’s stock.

WARNING: This piece of content was reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this piece of content on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.thelincolnianonline.com/2018/02/20/cleveland-research-downgrades-oracle-orcl-to-neutral.html.

Oracle Company Profile

Oracle Corporation (Oracle) provides products and services that address all aspects of corporate information technology (IT) environments, including application, platform and infrastructure. The Company’s businesses include cloud and on-premise software, hardware and services. Its cloud and on-premise software business consists of three segments, including cloud software and on-premise software, which includes Software as a Service (SaaS) and Platform as a Service (PaaS) offerings, cloud infrastructure as a service (IaaS) and software license updates and product support.

Analyst Recommendations for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply